Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Li Mei Poon, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Poh Lin Tan, Ziyi LIM, Balamurugan Vellayappan, Rajat Bhattacharyya, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Teck Guan Soh, Colin Phipps Diong, Wing H. Leung, MD PhD, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 2039.

https://doi.org/10.1182/blood-2019-128014

Published: 2019

Journal Articles

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Michael Low Cardenas, MD, Mehrdad Abedi, MD, Christina Romo, Carol M. Richman, MD, Megan Daly, MD, Joseph Tuscano, MD

Blood (2019) 134 (Supplement_1): 3334.

https://doi.org/10.1182/blood-2019-130870

Published: 2019

Journal Articles

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

Michael A Spinner, MD, Vanessa E Kennedy, MD, John S Tamaresis, PhD, Philip W Lavori, PhD, Linda V Elder, BA, Sally Arai, MD, Laura J Johnston, MD, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Richard T Hoppe, MD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2018) 132 (Supplement 1): 4638.

https://doi.org/10.1182/blood-2018-99-113597

Published: 2018

Journal Articles

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Yazan Migdady, MD MSc, Ridhi Gupta, MBBS, Asiri Ediriwickrema, MD, Francisco Socola, MD, Sally Arai, MD, Beth A Martin, MD

Blood (2018) 132 (Supplement 1): 4976.

https://doi.org/10.1182/blood-2018-99-116560

Published: 2018

Journal Articles

A Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) in Combination with Cyclophosphamide and Etoposide in Patients with Relapsed/Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood (2017) 130 (Supplement 1): 4607.

https://doi.org/10.1182/blood.V130.Suppl_1.4607.4607

Published: 2017

Journal Articles

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Michael A. Spinner, MD, Lori S. Muffly, MD MS, Sally Arai, MD, Laura Johnston, MD, Everett H. Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2017) 130 (Supplement 1): 2003.

https://doi.org/10.1182/blood.V130.Suppl_1.2003.2003

Published: 2017

Journal Articles

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Andreas T Björklund, MD PhD MSc, Mattias Carlsten, MD PhD, Ebba Sohlberg, PhD, Trevor Clancy, Lisa Liu, Mohsen Karimi, PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Emma Watz, Björn Engelbrekt Wahlin, Marzia Palma, MD PhD, Lotta Hansson, Per Ljungman, Eva Hellstrom-Lindberg, MD PhD, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, MD PhD

Blood (2017) 130 (Supplement 1): 4458.

https://doi.org/10.1182/blood.V130.Suppl_1.4458.4458

Published: 2017

Journal Articles

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Andrea Velardi, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Adelmo Terenzi, MD, Loredana Ruggeri, MD PhD, Antonio Pierini, MD PhD, Sara Piccinelli, MD, Sara Tricarico, MD, Amico Lucia, MD, Genni Casarola, MD, Valentina Lancillotta, MD, Simonetta Saldi, MD, Mauro Di Ianni, MD PhD, Cynthia Aristei, MD PhD, Massimo Fabrizio Martelli, MD PhD

Blood (2017) 130 (Supplement 1): 4601.

https://doi.org/10.1182/blood.V130.Suppl_1.4601.4601

Published: 2017

Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD

Blood (2016) 128 (22): 4669.

https://doi.org/10.1182/blood.V128.22.4669.4669

Published: 2016

Journal Articles

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Anthony Selwyn Stein, MD, Jeffrey Y. C. Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, Biostatition, Pablo Miguel Parker, MD, Ricardo Spielberger, MD, Len Farol, MD, Guido Marcucci, MD, Eric Radany, MD, Tim Schultheiss, MD, An Liu, MD, Ibrahim Aldoss, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 735.

https://doi.org/10.1182/blood.V126.23.735.735

Published: 2015

Journal Articles

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Aaron C. Logan, MDPhD, Alex F. Herrera, MD, Christine E. Ryan, Andrew R. Rezvani, MD, Katherine A. Kong, PhD, Malek Faham, MD PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Rachel L. Sargent, MD, Edwin P. Alyea, MD, Vincent T. Ho, MD, Jennifer R. Brown, MD PhD, Jerome Ritz, MD, David B. Miklos, MD PhD

Blood (2015) 126 (23): 4340.

https://doi.org/10.1182/blood.V126.23.4340.4340

Published: 2015

Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD

Blood (2015) 126 (23): 624.

https://doi.org/10.1182/blood.V126.23.624.624

Published: 2015

Journal Articles

Long-Term Follow up of Pediatric Patients with Hodgkin Lymphoma Treated with High Dose Therapy and Autologous Stem Cell Transplantation

Lisa Giulino Roth, MD, Tara O'Donohue MD, Tanya Trippett, MD, Elizabeth Klein, MPH, Nancy A. Kernan, MD, Rachel Kobos, MD, Susan Prockop, MD, Andromachi Scaradavou, MD, Neerav Shukla, MD, Peter G Steinherz, MD, Alison J Moskowitz, MD, Craig H. Moskowitz, MD, Farid Boulad, MD

Blood (2015) 126 (23): 2000.

https://doi.org/10.1182/blood.V126.23.2000.2000

Published: 2015

Journal Articles

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Blood (2015) 126 (23): 3232.

https://doi.org/10.1182/blood.V126.23.3232.3232

Published: 2015

Journal Articles

Use of High-Throughput Sequencing (HTS) of TCRß to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Richard T. Hoppe, MD, Everett H. Meyer, MD PhD, Youn H. Kim, MD

Blood (2014) 124 (21): 2473.

https://doi.org/10.1182/blood.V124.21.2473.2473

Published: 2014

Journal Articles

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Hideki Nakasone, Mats Remberger, PhD, Lu Tian, PhD, Petter Brodin, MD PhD, Bita Sahaf, Fang Wu, Robert Lowsky, MD, Jonas Mattsson, MD PhD, Robert S. Negrin, MD, David B. Miklos, Everett Meyer, MD PhD

Blood (2014) 124 (21): 2537.

https://doi.org/10.1182/blood.V124.21.2537.2537

Published: 2014

Journal Articles

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Laura Johnston, MD, Ginna G. Laport, MD, Robert Lowsky, MD, David B. Miklos, Judith A. Shizuru, MD PhD, Jonathan E. Benjamin, Robert S. Negrin, MD, Sunil Reddy, MD, Lynn Million, MD, Richard T. Hoppe, MD, Youn H. Kim, MD

Blood (2014) 124 (21): 2544.

https://doi.org/10.1182/blood.V124.21.2544.2544

Published: 2014

Journal Articles

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia

Andreas T Björklund, MDPhD, Mattias Carlsten, MD PhD, Marie Schaffer, PhD, Lisa Liu, MD, Sarah A. Cooley, MD MS, Jeffrey S. Miller, MD, Emma Watz, MD, Marzia Palma, MD PhD, Lotta Hansson, MD PhD, Björn E Wahlin, MD PhD, Lars Möllgård, MDPhD, Hans Hagglund, MD PhD, Pontus Blomberg, PhD, Per T. Ljungman, MD PhD, Eva Hellström-Lindberg, MD PhD, Hans-Gustaf Ljunggren, MD PhD, Karl-Johan Malmberg, MD, PhD

Blood (2014) 124 (21): 1120.

https://doi.org/10.1182/blood.V124.21.1120.1120

Published: 2014

Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Yves Beguin, MD PhD, Pierre Zachee, MD PhD, Johan Maertens, MD PhD, Tessa Kerre, MD PhD, Aurelie Ory, Laurence Seidel, Carlos Graux, MD PhD, Philippe Lewalle, MD PhD, Michel Van Gelder, PhD MD, Koen Theunissen, Evelyne Willems, MD PhD, Marie-Paule Emonds, Ann De Becker, Frederic Baron

Blood (2014) 124 (21): 542.

https://doi.org/10.1182/blood.V124.21.542.542

Published: 2014

Journal Articles

Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment

Antonia M. S. Müller, Jessica Poyser, Natascha J. Küpper, Cassandra Burnett, Rose M. Ko, Holbrook E.K. Kohrt, Mareike Florek, Pei Zhang, Robert S. Negrin, Judith A. Shizuru

Blood (2014) 123 (18): 2882–2892.

https://doi.org/10.1182/blood-2013-10-530212

Published: 2014

Includes: Supplemental data

NARROW

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

A Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) in Combination with Cyclophosphamide and Etoposide in Patients with Relapsed/Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Long-Term Follow up of Pediatric Patients with Hodgkin Lymphoma Treated with High Dose Therapy and Autologous Stem Cell Transplantation

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Use of High-Throughput Sequencing (HTS) of TCRß to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only